Route of Immunization and the Therapeutic Impact of Recombinant Anticancer Vaccines
- 5 March 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (5) , 390-392
- https://doi.org/10.1093/jnci/89.5.390
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA VaccineJNCI Journal of the National Cancer Institute, 1995
- IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.The Journal of Immunology, 1995
- Fowlpox Virus Host Range Restriction: Gene Expression, DNA Replication, and Morphogenesis in Nonpermissive Mammalian CellsVirology, 1993
- Vaccinia Virus: A Tool for Research and Vaccine DevelopmentScience, 1991
- Humoral and cell‐mediated immune responses to recombinant vaccinia viruses in miceImmunology & Cell Biology, 1989
- Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.The Journal of Immunology, 1987